• Fujirebio Europe N.V. launches iAMP® COVID-19, a new molecular detection assay that eliminates the need for RNA extraction

    17 hours ago

  • Biogazelle initiates large-scale testing of COVID-19 in Belgium

    Thursday April 2nd 2020

  • iTeos Therapeutics Closes $125 Million Series B2 Financing

    Thursday April 2nd 2020

  • Mithra Announces Donesta® Phase III Clinical Program Update

    Thursday April 2nd 2020

  • Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

    Tuesday March 31st 2020

  • Belgische biotech sector blijft draaien ondanks de coronacrisis

    Friday March 27th 2020

  • Biocartis kondigt co-commercialisatie aan van de SeptiCyte® RAPID Test op Idylla™ (CE-IVD) en brengt update over COVID-19 impact

    Friday March 27th 2020

  • miDiagnostics Raises €14m to Accelerate the Commercialization of its Disruptive, Lab-quality Silicon Chip Diagnostics Platform

    Thursday March 26th 2020

  • Your news here?

  • University hospital Ghent and VIB are testing medication to treat COVID-19-associated respiratory illness

    Wednesday March 25th 2020

  • iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

    Wednesday February 26th 2020

  • Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS

    Monday January 13th 2020


Strategic Partners